These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32166009)

  • 21. Serum Uric Acid Levels and Risk of Rapid Decline of Estimated Glomerular Filtration Rate in Patients with Type 2 Diabetes: Findings from a 5-Year Prospective Cohort Study.
    Le HT; Le TT; Tran NMT; Nguyen TTT; Minh NCS; Le QT; Tram TAT; Tran TD; Doan TX; Duong MHT; Thai TT
    Healthcare (Basel); 2021 Oct; 9(10):. PubMed ID: 34683020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
    Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
    Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors for the development of microalbuminuria and interaction with renal function.
    Chatzikyrkou C; Menne J; Izzo J; Viberti G; Rabelink T; Ruilope LM; Rump C; Mertens PR; Haller H
    J Hypertens; 2017 Dec; 35(12):2501-2509. PubMed ID: 29035939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral arterial stiffness is independently associated with a rapid decline in estimated glomerular filtration rate in patients with type 2 diabetes.
    Sheen YJ; Lin JL; Li TC; Bau CT; Sheu WH
    Biomed Res Int; 2013; 2013():309294. PubMed ID: 24471138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study.
    Fujita Y; Doi Y; Hamano T; Hatazaki M; Umayahara Y; Isaka Y; Tsubakihara Y
    Sci Rep; 2019 Oct; 9(1):14871. PubMed ID: 31619722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Independent risk factors of rapid glomerular filtration rate decline in patients with type 2 diabetes with preserved kidney function and normoalbuminuria: A multicenter cohort study.
    Hirano D; Unoki-Kubota H; Imasawa T; Yamamoto-Honda R; Kajio H; Yamashita S; Fukazawa Y; Seki N; Noda M; Kaburagi Y
    J Diabetes Investig; 2023 Jul; 14(7):874-882. PubMed ID: 37026171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the initial decline in estimated glomerular filtration rate on the risk of new-onset atrial fibrillation and adverse cardiovascular and renal events in patients with type 2 diabetes treated with sodium-glucose co-transporter-2 inhibitors.
    Chan YH; Chen SW; Chao TF; Kao YW; Huang CY; Chu PH
    Diabetes Obes Metab; 2021 Sep; 23(9):2077-2089. PubMed ID: 34047459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haptoglobin genotype and renal function decline in type 1 diabetes.
    Costacou T; Ferrell RE; Ellis D; Orchard TJ
    Diabetes; 2009 Dec; 58(12):2904-9. PubMed ID: 19720796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease and type 2 diabetes.
    Miyoshi H; Kameda H; Yamashita K; Nakamura A; Kurihara Y
    J Diabetes Investig; 2019 Nov; 10(6):1510-1517. PubMed ID: 31026373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
    Nosadini R; Velussi M; Brocco E; Bruseghin M; Abaterusso C; Saller A; Dalla Vestra M; Carraro A; Bortoloso E; Sambataro M; Barzon I; Frigato F; Muollo B; Chiesura-Corona M; Pacini G; Baggio B; Piarulli F; Sfriso A; Fioretto P
    Diabetes; 2000 Mar; 49(3):476-84. PubMed ID: 10868971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
    Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study.
    Barr EL; Barzi F; Hughes JT; Jerums G; O'Dea K; Brown AD; Ekinci EI; Jones GR; Lawton PD; Sinha A; MacIsaac RJ; Cass A; Maple-Brown LJ
    Nephrology (Carlton); 2018 Jul; 23(7):682-689. PubMed ID: 28503768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials.
    Mann JFE; Hansen T; Idorn T; Leiter LA; Marso SP; Rossing P; Seufert J; Tadayon S; Vilsbøll T
    Lancet Diabetes Endocrinol; 2020 Nov; 8(11):880-893. PubMed ID: 32971040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher glucose fluctuation is associated with a higher risk of cardiovascular disease: Insights from pooled results among patients with diabetes.
    Li F; Zhang L; Shen Y; Liu HH; Zhang ZY; Hu G; Wang RX
    J Diabetes; 2023 May; 15(5):368-381. PubMed ID: 37070713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of long-term past glycemic control on executive function among patients with type 2 diabetes mellitus.
    Minami T; Ito Y; Yamada M; Furuta R; Minagawa F; Kamata K; Kameda A; Terauchi Y
    Diabetol Int; 2020 Apr; 11(2):114-120. PubMed ID: 32206481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation Between Glycemic Variability and Diabetic Complications: A Narrative Review.
    Huang L; Pan Y; Zhou K; Liu H; Zhong S
    Int J Gen Med; 2023; 16():3083-3094. PubMed ID: 37496596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between fasting plasma glucose variability and incident eGFR decline: evidence from two cohort studies.
    Deravi N; Sharifi Y; Koohi F; Zadeh SST; Masrouri S; Azizi F; Hadaegh F
    BMC Public Health; 2023 Mar; 23(1):565. PubMed ID: 36973769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of CPAP on blood glucose fluctuation in patients with type 2 diabetes mellitus and obstructive sleep apnea.
    Zhao X; Zhang W; Xin S; Yu X; Zhang X
    Sleep Breath; 2022 Dec; 26(4):1875-1883. PubMed ID: 35165839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring.
    Jackson MA; Ahmann A; Shah VN
    Diabetes Technol Ther; 2021 Mar; 23(S1):S27-S34. PubMed ID: 33534631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.